Skip to content

Hemab Therapeutics Holdings

US · COAG #3007 by market cap Listed 2026
28.70 +0.33 +1.16%
Live - 5344 symbols - heartbeat 152s ago · 2026-10-08 02:52
After-hours 28.70 0.00%
Overnight 28.37 -1.15%
Market cap
1.34B
P/B
2.95
EPS
-1.45
Reader sentiment Are you bullish or bearish on COAG?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $42
    Market Newswire · 2026/6/30
  • H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $60
    Market Newswire · 2026/8/12
  • Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $64
    Market Newswire · 2026/8/12
  • Rating change
    Goldman Sachs Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $36
    Market Newswire · 2026/5/26
  • Rating change
    Hemab Therapeutics Holdings, Inc. (COAG) Receives a Buy From Wedbush
    TipRanks · 2026/6/30
  • Rating change
    Jefferies Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $39
    Market Newswire · 2026/6/9
  • Rating change
    Wedbush Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $42
    Market Newswire · 2026/5/26
  • Hemab Therapeutics Holdings, Inc. (COAG) Gets a Buy From Wedbush
    TipRanks · 2026/8/12
  • Rating change
    Evercore Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $50
    Market Newswire · 2026/5/26
  • Rating change
    H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/6/27
  • Rating change
    H.C. Wainwright Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $40
    Market Newswire · 2026/6/17
  • Rating change
    Jefferies Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $39
    Market Newswire · 2026/5/26
  • Rating change
    Jefferies Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/7/14
  • Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2026/7/14
  • Rating change
    H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $52
    Market Newswire · 2026/7/13

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 02:52:22 · For reference only, not investment advice and not tailored to your situation.